Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IDIBELL Participates in the Creation of a Bioinformatics Platform to Promote Education

Published: Monday, February 18, 2013
Last Updated: Monday, February 18, 2013
Bookmark and Share
One of its objectives is to turn the Barcelona area into an international reference in the field of bioinformatics, based on its scientific excellence and resources.

IDIBELL, along with nine other research institutions in the field of biomedicine, three Catalan universities, the Barcelona Supercomputing Center-Centro National de Supercomputación (BSC-CNS) and BioCat signed on February 14th an agreement for the creation of the Bioinformatics Barcelona (BiB), a platform which aims is to turn the Barcelona area as global reference center in bioinformatics, through cooperation between universities, research centers, and other public and private entities.

Bioinformatics is an area of research in applied computer science and information technology used for the treatment of biological data. BiB promoters consider this area as strategic science that makes sense of the vast amounts of biological data generated. So BiB proposes to boost this area of specialization that is necessary in all areas of life sciences and has a profound impact on fields as diverse as human health, the food industry, the environment and biotechnology.

Promoting high-level postgraduate studies

It seeks to take advantage of the critical mass of internationally renowned researchers in bioinformatics in the Barcelona area to promote high-level postgraduate studies, including the training of new professionals, and to develop scientific and transfer knowledge initiatives.
 
The agreement is a commitment between the different institutions to develop, within six months, the strategic plan to formally constitute the initiative. The task of preparing this plan will be led by Anna Ripoll, Professor of Architecture and Computer Technology and rector at  the Autonomous University of Barcelona (UAB), who will be its executive chairman. Ferran Sanz, head of Biomedical Informatics at the UPF, will be its scientific director.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Method Developed to Diagnose Hereditary Breast and Ovarian Cancer
Massive sequencing algorithm and bioinformatic analysis to detect very efficiently genetic mutations linked to the disease.
Wednesday, January 16, 2013
Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!